91ɫƵ Ophthalmology and Vision Sciences Research
About Our Research
A broad spectrum of funding sources, from individual donations to National Institute of Health grants, enables our researchers to take a multidisciplinary approach to improving the fundamental understanding, diagnosis and management of eye disease. As a leader in clinical and translational research, Vision Science Research at 91ɫƵ supports a solid platform for innovation, collaboration and discovery.
Vision Scientists
Explore the diverse research interests of the Eye Institute faculty and our vision science network.
Vision Science Resources
Shared resources support diverse vision research programs from faculty at 91ɫƵ, and we are always interested in engaging with non-vision scientists from 91ɫƵ or other institutions.
Advanced Ocular Imaging Program
The Advanced Ocular Imaging Program, located in the Eye Institute, serves as a local, national and international resource for advancing the field of ocular imaging and for translating adaptive optics technology into a clinically relevant imaging tool.
Collery Laboratory
91ɫƵ's Collery lab seeks to understand mechanisms that underlie signaling and development in the eye that both contribute to retinal health, as well as influence eye size and refractive error.
Miesfeld Laboratory
The Miesfeld laboratory is interested in understanding the gene regulatory networks associated with development and disease of the neural retina, with a focus on retinal ganglion cells (RGCs), the pathogenic target in glaucoma.
Ocular Gene Therapy Laboratory
The Ocular Gene Therapy Laboratory (OGTL), founded by Daniel M. Lipinski, MSc, DPhil, and located in the Eye Institute, aims to develop broadly applicable gene-based therapeutics to prevent human blindness arising from neurodegenerative or vascular diseases affecting the retina.
Ocular Immunology and Angiogenesis Laboratory
The Ocular Immunology and Angiogenesis Lab focuses on the identification and validation of novel biomarkers and targets to evaluate potential VEGF-independent Next-Generation Therapeutics countering Ocular Fibrotic and Angiogenic Diseases.
Scalabrino Laboratory
The main goal of the Scalabrino Lab is to halt inherited retinal disorders by studying retinal circuitry and engineering new molecular therapies that better address the dysfunction.
91ɫƵ's Ophthalmology Clinical Trials and Research Studies
First, clinical trials may offer additional treatment options — with the same hands-on comprehensive care found throughout the Froedtert & the 91ɫƵ health network. And as volunteers, you are pioneers in research at the forefront of innovation.
Second, your participation in these trials or other research studies helps make advancements in vision care. This kind of research allows scientists to better understand blinding eye diseases and discover the best ways to treat or prevent them. When you take part in any research study at the Eye Institute, you contribute to the larger mission of improving vision care for everyone.
Research Studies Frequently Asked Questions
Funding
We are fortunate to have a diverse array of funding sources for our research at the Eye Institute. We would like to acknowledge the National Institute of Health (NIH), the National Eye Institute (NEI), Research to Prevent Blindness, and the R.D. & Linda Peters Foundation for their long-term support of our research projects. We also gratefully thank the many other local and national foundations who have made contributions to advance our mission. Finally, we thank our patients for their philanthropic donations, which provide especially vital support for new projects and continued innovation.